- Interim 12-Week Data Suggest At Least Comparable Antiviral ... (Hep C Treatment)

- Interim 12-Week Data Suggest At Least Comparable Antiviral ...
PR Newswire (press release), NY - Mar 14, 2006... the efficacy and safety of Albuferon(TM) (albumin-interferon alpha 2b) in combination with ribavirin in patients with genotype 1 chronic hepatitis C who are ...

FDA Sends Intermune Letter Over Advertisement
PharmaLive.com (press release), PA - 8 hours ago... a proven treatment option for the significant and growing number of nonresponders and relapsers," referring to patients with chronic hepatitis C virus (HCV ...

Peregrine Pharmaceuticals Files Shelf Registration Statement
International News Service, Australia - Mar 31, 2006... In February, Peregrine successfully completed enrollment in a Tarvacin Phase l clinical trial for the treatment of chronic hepatitis C virus infection ...

Iron overload does not affect HCV genotype and response to ...
Therapeutics Daily (subscription) (press release), PA - Mar 27, 2006... They continued, "Liver tissue samples from 95 patients with chronic hepatitis C were divided into two groups: group I, presence of iron overload in hepatic ...

Valeant Pharmaceuticals Reports VISER1 Results for Viramidine(R) ...
Finanzen.net, Germany - Mar 21, 2006... prodrugof ribavirin, in oral form, for administration in combination with apegylated interferon for the treatment of chronic hepatitis C intreatment-naive ...